Mitochondrial Inhibitor Models of Huntington’s Disease and Parkinson’s Disease Induce Zinc Accumulation and Are Attenuated by Inhibition of Zinc Neurotoxicity in vitro or in vivo

Publisher： Karger

E-ISSN： 1660-2862|11|1|49-58

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.11, Iss.1, 2012-05, pp. : 49-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Huntington’s Disease – New Perspectives Based on Neuroendocrine Changes in Rodent Models

By  

Neurodegenerative Diseases, Vol. 6, Iss. 4, 2009-06 ,pp. : 154-164

Karger

Access to resources Recommend Favorite

Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease

By Büeler Hansruedi  

Apoptosis, Vol. 15, Iss. 11, 2010-11 ,pp. : 1336-1353

Springer Publishing Company

Access to resources Recommend Favorite

N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington’s Disease

By  

Neurodegenerative Diseases, Vol. 9, Iss. 3, 2012-02 ,pp. : 145-157

Karger

Access to resources Recommend Favorite

Parkinson’s disease: clinical aspects

By Klockgether Thomas  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 115-120

Springer Publishing Company

Access to resources Recommend Favorite

Neuronal pathology in Parkinson’s disease

By Schulz Jörg   Falkenburger Björn  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 135-147

Springer Publishing Company

Access to resources Recommend Favorite